HELE Quote, Financials, Valuation and Earnings

European Wax Center has a net margin of 10.48% compared to Helen Of Troy's net margin of 3.37%. Helen Of Troy's return on equity of 7.67% beat European Wax Center's return on equity of 9.03%.

Helen Of Troy has a consensus price target of $49.00, signalling upside risk potential of 86.74%. On the other hand European Wax Center has an analysts' consensus of $6.71 which suggests that it could grow by 30.38%. Given that Helen Of Troy has higher upside potential than European Wax Center, analysts believe Helen Of Troy is more attractive than European Wax Center.

Helen Of Troy has a beta of 0.912, which suggesting that the stock is 8.84% less volatile than S&P 500. In comparison European Wax Center has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Helen Of Troy has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. European Wax Center offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen Of Troy pays -- of its earnings as a dividend. European Wax Center pays out 7.54% of its earnings as a dividend. European Wax Center's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Helen Of Troy quarterly revenues are $485.9M, which are larger than European Wax Center quarterly revenues of $51.4M. Helen Of Troy's net income of $50.9M is higher than European Wax Center's net income of $1.7M. Notably, Helen Of Troy's price-to-earnings ratio is 4.87x while European Wax Center's PE ratio is 25.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen Of Troy is 0.32x versus 1.08x for European Wax Center. Usually stocks with elevated PS ratios are considered overvalued.

Hims & Hers Health has a net margin of 10.48% compared to Helen Of Troy's net margin of 8.44%. Helen Of Troy's return on equity of 7.67% beat Hims & Hers Health's return on equity of 37.84%.

Helen Of Troy has a consensus price target of $49.00, signalling upside risk potential of 86.74%. On the other hand Hims & Hers Health has an analysts' consensus of $46.95 which suggests that it could fall by -14.37%. Given that Helen Of Troy has higher upside potential than Hims & Hers Health, analysts believe Helen Of Troy is more attractive than Hims & Hers Health.

Helen Of Troy has a beta of 0.912, which suggesting that the stock is 8.84% less volatile than S&P 500. In comparison Hims & Hers Health has a beta of 1.846, suggesting its more volatile than the S&P 500 by 84.575%.

Helen Of Troy has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hims & Hers Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen Of Troy pays -- of its earnings as a dividend. Hims & Hers Health pays out -- of its earnings as a dividend.

Helen Of Troy quarterly revenues are $485.9M, which are smaller than Hims & Hers Health quarterly revenues of $586M. Helen Of Troy's net income of $50.9M is higher than Hims & Hers Health's net income of $49.5M. Notably, Helen Of Troy's price-to-earnings ratio is 4.87x while Hims & Hers Health's PE ratio is 79.46x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen Of Troy is 0.32x versus 7.41x for Hims & Hers Health. Usually stocks with elevated PS ratios are considered overvalued.

The Beauty Health has a net margin of 10.48% compared to Helen Of Troy's net margin of -14.51%. Helen Of Troy's return on equity of 7.67% beat The Beauty Health's return on equity of -66.39%.

Helen Of Troy has a consensus price target of $49.00, signalling upside risk potential of 86.74%. On the other hand The Beauty Health has an analysts' consensus of $1.63 which suggests that it could grow by 1.45%. Given that Helen Of Troy has higher upside potential than The Beauty Health, analysts believe Helen Of Troy is more attractive than The Beauty Health.

Helen Of Troy has a beta of 0.912, which suggesting that the stock is 8.84% less volatile than S&P 500. In comparison The Beauty Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Helen Of Troy has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen Of Troy pays -- of its earnings as a dividend. The Beauty Health pays out -- of its earnings as a dividend.

Helen Of Troy quarterly revenues are $485.9M, which are larger than The Beauty Health quarterly revenues of $69.6M. Helen Of Troy's net income of $50.9M is higher than The Beauty Health's net income of -$10.1M. Notably, Helen Of Troy's price-to-earnings ratio is 4.87x while The Beauty Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen Of Troy is 0.32x versus 0.67x for The Beauty Health. Usually stocks with elevated PS ratios are considered overvalued.